Invesco
RLAY icon

Invesco’s Relay Therapeutics RLAY Stock Holding History

Invesco’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
692,584
+22,710
+3% +$330K ﹤0.01% 1767
2026
Q1 		$6.67M Sell
669,874
-195,607
-23% -$1.75M ﹤0.01% 2058
2025
Q4 		$7.32M Buy
865,481
+504,291
+140% +$3.6M ﹤0.01% 2044
2025
Q3 		$1.89M Buy
361,190
+87,807
+32% +$335K ﹤0.01% 2634
2025
Q2 		$946K Buy
273,383
+88,552
+48% +$263K ﹤0.01% 2865
2025
Q1 		$484K Buy
184,831
+65,414
+55% +$256K ﹤0.01% 3161
2024
Q4 		$492K Buy
119,417
+5,261
+5% +$28.6K ﹤0.01% 3242
2024
Q3 		$808K Sell
114,156
-357
-0.3% -$2.67K ﹤0.01% 3005
2024
Q2 		$747K Sell
114,513
-2,370
-2% -$16.2K ﹤0.01% 3091
2024
Q1 		$970K Sell
116,883
-30,198
-21% -$295K ﹤0.01% 3007
2023
Q4 		$1.62M Sell
147,081
-6,227
-4% -$52.5K ﹤0.01% 2694
2023
Q3 		$1.29M Buy
153,308
+26,424
+21% +$284K ﹤0.01% 2753
2023
Q2 		$1.59M Buy
126,884
+52,931
+72% +$658K ﹤0.01% 2710
2023
Q1 		$1.22M Buy
73,953
+15,085
+26% +$270K ﹤0.01% 2830
2022
Q4 		$879K Buy
58,868
+1,061
+2% +$20.3K ﹤0.01% 2991
2022
Q3 		$1.29M Buy
57,807
+188
+0.3% +$4.13K ﹤0.01% 2830
2022
Q2 		$966K Buy
57,619
+4,293
+8% +$92K ﹤0.01% 3006
2022
Q1 		$1.6M Buy
53,326
+23,491
+79% +$570K ﹤0.01% 2873
2021
Q4 		$917K Buy
29,835
+2,440
+9% +$77.1K ﹤0.01% 3111
2021
Q3 		$864K Buy
27,395
+4,118
+18% +$139K ﹤0.01% 3174
2021
Q2 		$852K Buy
23,277
+13,725
+144% +$452K ﹤0.01% 3193
2021
Q1 		$330K Buy
9,552
+2,548
+36% +$111K ﹤0.01% 3515
2020
Q4 		$291K Buy
+7,004
New +$317K ﹤0.01% 3431

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Invesco's RLAY Position: Q2 2026 in Review

Invesco increased its Relay Therapeutics (RLAY) stake by 3.4% in Q2 2026, buying an estimated $330K and bringing the position to 692,584 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

Invesco first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Invesco held 692,584 shares of Relay Therapeutics worth $13M as of Q2 2026.
  • Invesco bought 22,710 Relay Therapeutics shares in Q2 2026, an estimated $330K.
  • Relay Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #1767 holding.
  • Invesco first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.